MICHELLE DALLAS: Open Payments
NPI 1992110860 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 24 payments from 11 companies in 2025. Trend: 2023 $743 · 2024 $640 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $156 |
| PFIZER INC. | 4 | $69 |
| Novo Nordisk Inc | 3 | $45 |
| Abbott Laboratories | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: UBRELVY, QULIPTA, FREESTYLE LIBRE 3, PREVNAR 20, JARDIANCE, Wegovy, NURTEC ODT, SHINGRIX.
Industry payments across AR — which companies pay providers there.
